PositiveDouble Blind Clinical Trial2012
Early survival of comatose patients after severe traumatic brain injury with the dual cannabinoid CB1/CB2 receptor agonist KN38-7271: a randomized, double-blind, placebo-controlled phase II trial
Classification Results
AI Classification
PositiveFine-tuned Classification
Positive